Applications established for R&D stages of therapy or vaccine that will be produced through bioprocessing SARS-CoV-2.
The mammalian cell lines that are engineered to produce high-value recombinant-protein drugs also produce unwanted proteins that reduce drug quality and increase production costs. Researchers have now introduced a CRISPR-Cas9 genome-editing technique that can eliminate up to 70% of the contaminating protein by mass in recombinant-protein drugs produced by CHO cells, workhorses of biotherapeutic protein production.
Funds will support development, validation, vaccine trials, and regulatory clearance.
Cruiserath plant in Dublin set to close by end of 2015, idling all 130 workers; another 30 to be axed at Swords.
Award focused on manufacturing and storage of the companies’ Ebola prime-boost vaccine regimen candidate.
Cesca says its automated cell processing system provides greater cell yields, higher consistency in a fraction of the time compared with traditional manual cell processing methods
Biomanufacturing professionals are enthusiastic about continuous processing because they believe it will have a significant impact on how their customers bring therapies to market, delivering them to patients faster and more cost effectively. MilliporeSigma officials...
The collaboration significantly increases both companies’ existing commercial capacity and simplifies the supply chain process for manufacture of viral vectors for use in gene therapy and immunotherapy.
Please wait while you are redirected to the right page...